Peer-reviewed articles

Morgan E, Arnold M, Rutherford MJ, et al. The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project). Int J Cancer. 2021;149(5):1013-1020. doi:10.1002/ijc.33620

Girardi F, Rous B, Stiller CA, et al. The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3). Neuro-Oncology. 2021;23(10):1765-1776. doi:10.1093/neuonc/noab067

Rosato V, Gómez-Rubio P, Molina-Montes E, et al. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study. Eur J Cancer Prev. 2021;30(6):423-430. doi:10.1097/CEJ.0000000000000588

Clarke N, Dunne S, Coffey L, et al. Health literacy impacts self-management, quality of life and fear of recurrence in head and neck cancer survivors. J Cancer Surviv. 2021;15(6):855-865. doi:10.1007/s11764-020-00978-5

Keeling E, O’Leary E, Deady S, O Neill JP, Conlon PJ, Moloney FJ. Gender and immunosuppression impact on Merkel cell carcinoma diagnosis and prognosis. A population based cohort study. Skin Health Dis. 2022;2(1):e80. doi:10.1002/ski2.80

Molcho M, Thomas AA, Walsh PM, Skinner R, Sharp L. Social inequalities in treatment receipt for childhood cancers in Ireland: A population-based analysis. Int J Cancer. 2022;150(6):941-951. doi:10.1002/ijc.33856

Araghi M, Fidler-Benaoudia M, Arnold M, et al. International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study. Thorax. 2022;77(4):378-390. doi:10.1136/thoraxjnl-2020-216555

O’Connell E, McDevitt J, Hill ADK, McNamara DA, Burke JP. Centralisation of rectal cancer care has improved patient survival in the republic of Ireland. Eur J Surg Oncol. 2022;48(4):890-895. doi:10.1016/j.ejso.2021.10.031

Kelly M, O’Brien KM, Hannigan A. Specialist palliative cancer care in acute hospitals and place of death: a population study. BMJ Support Palliat Care. 2022;12(e1):e94-e102. doi:10.1136/bmjspcare-2020-002232

Anderson S, Breen KJ, Davis NF, Deady S, Sweeney P. Penile cancer in Ireland - A national review. Surgeon. 2022;20(3):187-193. doi:10.1016/j.surge.2021.04.004

Menzies S, O’Leary E, Callaghan G, et al. A population-based comparison of organ transplant recipients in whom cutaneous squamous cell develops versus those in whom basal cell carcinoma develops. J Am Acad Dermatol. 2022;86(6):1377-1379. doi:10.1016/j.jaad.2021.05.032

Sexton GP, Walsh P, Moriarty F, O’Neill JP. The changing face of Irish head and neck cancer epidemiology: 20 years of data. Eur Arch Otorhinolaryngol. 2022;279(6):3079-3088. doi:10.1007/s00405-021-07118-4

Ssenyonga N, Stiller C, Nakata K, et al. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. The Lancet Child & Adolescent Health. 2022;6(6):409-431. doi:10.1016/S2352-4642(22)00095-5

Vener C, Rossi S, Minicozzi P, et al. Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials. Front Oncol. 2022;12:892684. doi:10.3389/fonc.2022.892684

Arnold M, Morgan E, Bardot A, et al. International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study). Gut. 2022;71(8):1532-1543. doi:10.1136/gutjnl-2021-325266

Cardoso R, Guo F, Heisser T, et al. Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study. Lancet Gastroenterol Hepatol. 2022;7(8):711-723. doi:10.1016/S2468-1253(22)00084-X

Di Carlo V, Stiller CA, Eisemann N, et al. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000–2014 in 59 countries (CONCORD-3). British Journal of Dermatology. 2022;187(3):364-380. doi:10.1111/bjd.21274

Sharkey Ochoa I, O’Regan E, Toner M, et al. The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2022;14(17). doi:10.3390/cancers14174321

Cardoso R, Guo F, Heisser T, et al. Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries. Lancet Reg Health Eur. 2022;21:100458. doi:10.1016/j.lanepe.2022.100458

Nikšić M, Matz M, Valkov M, et al. World-wide trends in net survival from pancreatic cancer by morphological sub-type: An analysis of 1,258,329 adults diagnosed in 58 countries during 2000–2014 (CONCORD-3). Cancer Epidemiology. 2022;80:102196. doi:10.1016/j.canep.2022.102196

Botta L, Gatta G, Didonè F, Lopez Cortes A, Pritchard-Jones K, the BENCHISTA Project Working Group. International benchmarking of childhood cancer survival by stage at diagnosis: The BENCHISTA project protocol. Tiao G, ed. PLoS ONE. 2022;17(11):e0276997. doi:10.1371/journal.pone.0276997

Botta L, Gatta G, Capocaccia R, et al. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study. Lancet Oncol. 2022;23(12):1525-1536. doi:10.1016/S1470-2045(22)00637-4

Morgan E, O’Neill C, Bardot A, Walsh P, Soerjomataram I, Arnold M. The Challenges of Collecting Long-Term Outcomes in Cancer Patients on the Population-Level: The Case of Metastatic Breast Cancer. J Registry Manag. 2023;50(4):173-175.

Doyle C, Brennan A, Wolinska A, et al. Incidence of Merkel cell carcinoma in the Republic of Ireland (1994–2019). International Journal of Dermatology. 2023;62(8). doi:10.1111/ijd.16661

Sexton GP, Walsh P, Moriarty F, O’Neill JP. Age Alone Is Not a Barrier to Concurrent Chemoradiotherapy for Advanced Head and Neck Cancer. Ann Otol Rhinol Laryngol. 2023;132(3):275-283. doi:10.1177/00034894221086087